Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 6 | $90,916 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Feb 2024 20:18 | RIGL | RIGEL PHARMACEUTICALS INC | SANTOS DAVID A | EVP, Chief Commercial Officer | 05 Feb 2024 | Sale | 8,918 | 1.14 | 10,167 | D |
06 Feb 2024 20:18 | RIGL | RIGEL PHARMACEUTICALS INC | SANTOS DAVID A | EVP, Chief Commercial Officer | 02 Feb 2024 | Sale | 5,601 | 1.13 | 6,329 | D |
06 Feb 2024 20:18 | RIGL | RIGEL PHARMACEUTICALS INC | SCHORNO DEAN L | EVP & Chief Financial Officer | 05 Feb 2024 | Sale | 7,027 | 1.14 | 8,011 | D |
06 Feb 2024 20:18 | RIGL | RIGEL PHARMACEUTICALS INC | SCHORNO DEAN L | EVP & Chief Financial Officer | 02 Feb 2024 | Sale | 5,601 | 1.1296 | 6,327 | D |
06 Feb 2024 20:18 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | 05 Feb 2024 | Sale | 30,545 | 1.14 | 34,821 | D |
06 Feb 2024 20:18 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | 02 Feb 2024 | Sale | 22,349 | 1.1303 | 25,261 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)